HLC immunobiotics is a unique combination of probiotics and nutrients that provides broad-spectrum support to the immune system as well as helps to bolster energy levels. Can be used at any time of the day, but is most effective when taken in the morning.
Enhanced immune support Boosts immunity with zinc and echinacea. Enhances antioxidant levels with vitamin C and CoQ10.
Increased energy support Increase energy levels with B-complex vitamins.1 Promote endurance with guaran.
High potency probiotic to optimize intestinal health High potency probiotic to optimize intestinal health.
Scientific Rationale:
Vitamin C and zinc support immune function.
Vitamin D and beta-glucan demonstrate immunological activity.
Guarana extract can temporarily promote alertness and wakefulness, enhance cognitive performance, relieve fatigue, promote endurance, and enhance motor performance.
Echinacea, elderberry and propolis help support immune function.
Serving Size: 1 capsule Servings Per Container: 30
Recommended Dosage: One capsule taken two times daily with meals, a few hours before or after taking other medications, or as professionally directed.
Risk information:
If you are experiencing nausea, fever, vomiting, bloody diarrhea or severe abdominal pain; if you have an immune-compromised condition; or if you are allergic to plants of the Asteraceae/Compositae/Daisy family, do not use.
If you are pregnant or breastfeeding or if you are allergic to bee products, poplar tree products or balsam of Peru, consult your healthcare practitioner prior to use.
If you have a progressive systemic disease such as tuberculosis, leukosis, collagenosis or multiple sclerosis; if you have high blood pressure, glaucoma and/or detrusor instability; or if you have a history of non-melanoma skin cancer, consult your healthcare practitioner prior to use.
If you are taking lithium, immunosuppressants or blood pressure medication, consult your healthcare practitioner prior to use. Consumption with other caffeine containing products or with natural health products or drugs which increase blood pressure is not recommended.
If symptoms of digestive upset occur, worsen or persist beyond three days, discontinue use and consult your healthcare practitioner. Hypersensitivity/allergy is known to occur; in which case, discontinue use.
3/30/2012 Ingredient Notice from Seroyal/Genestra regarding lactose, barley gluten and soy in the fermentation medium:
"We have been working to remove the allergens in the fermentation medium with great success. Lactose has been removed. Any lot number after 25322 has lactose free fermentation medium. We have also successfully removed gluten and soy from a research & development perspective. These allergen free fermentation mediums should be available soon."
These nutrients are digested by the micro-organisms during fermentation and further removed during centrifugation (after fermentation).
3/2/2011-Manufacturer's Notice
"We have tested the probiotics as worst-case scenarios based on total daily consumption and target populations and no gluten, dairy or soy was detected in the final product. Although our analytical assay for soy, gluten & dairy did not detect any proteins, these methods cannot detect total absence"
Read customer questions and answers about Nutrition Basics on our blog.
Seroyal research-driven probiotic therapies:
Clinically proven in randomized, double-blind, placebo-controlled human trials at 25 billion CFU** - Reduces symptoms of Irritable Bowel Syndrome (IBS)14 - Prevents intestinal microflora disruption post-antibiotics15, 16 - Reduces the incidence of C. difficile associated diarrhea17
Proprietary non-pathogenic human-sourced microflora bacterial strains - Strong epithelial adherence - Naturally high tolerance to stomach acid
Ambient-Safe - Manufacturing allows for ambient temperature (20-25C) storage and 2 year shelf-life without compromising product stability and still meet or exceed label claims.
References:
A Natural Health Products Directorate. Product Monograph Multi-Vitamin/Mineral Supplement [internet] October 22, 2007 [Accessed Sept 17 2010]. Available at: http://www.hc-sc.gc.ca/ dhp-mps/prodnatur/applications/licen-prod/monograph/multi_vitmin_suppl-eng.php.
Natural Health Products Directorate (NHPD). Product Monograph Caffeinated Energy Drinks. [internet] December 30, 2007 [Accessed Sept. 16, 2010]. Available at: http://www.hc-sc.gc.ca/ dhp-mps/alt_formats/hpfb-dgpsa/pdf/prodnatur/mono_caffe-cafe-eng.pd.
Natural Medicines Comprehensive Database. Vitamin D Monograph. [internet] Accessed: 17 Sept 2010. Available at: http://naturaldatabase.therapeuticresearch.com.ezproxy.ccnm.edu/nd/Search.as px?cs=&s=ND&pt=100&id=929&ds=&name=VITAMIN+D&searchid=22786210. Lehne G, Haneberg B, Gaustad P, Johansen PW, Preus H, Abrahamsen TG. Oral administration of a new soluble branched beta-1,3-D-glucan is well tolerated and can lead to increased salivary concentrations of immunoglobulin A in healthy volunteers. Clin Exp Immunol. 2006 Jan;143(1):65-9.
NHPD. Product Monograph Caffeinated Energy Drinks.
NMCD. Echinacea Monograph.
Vlachojannis JE, Cameron M, Chrubasik S. A sytematic review on the sambuci fructus effect and efficacy profiles. Phytother Res. 2010 Jan;24(1):1-8. Pubmed 17 Sept. 2010.
NMCD. Echinacea Monograph.
Lofty M. Biological Activity of Bee Propolis in Health and Disease. Asian Pac J Cancer Prev. 2006;7:22-31.
Lofty 2006
Williams EA, et al. Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study. 2009; 29(1): 97-103.
Plummer SF, et al. Effects of probiotics on the composition of the intestinal microbiota following antibiotic therapy. Int J Antimicrob Agents. 2005; 26(1); 69-74.
Madden JA, et al. Effect of probiotics on preventing disruption of the intestinal microflora following antibiotic therapy: a double-blind, placebo-controlled pilot study. Int Immunopharmacol. 2005; (6): 1091-7.
Plummer S, et al. Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea. Int Microbiol. 2004;7(1):59-62.